EUCTR2009-016082-29-BE进行中（未招募）不适用
Role of Lanreotide in the Management of Paraduodenal Pancreatitis - LPP
Erasme hospital0 个研究点目标入组 60 人开始时间: 2009年11月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with one or several of the following radiological criteria for paraduodenal pancreatitis will be selected to participate to the protocol: an occupying mass lesion in the pancreaticoduodenal groove (hypointense relative to the pancreatic tissue on T1-weighted images and iso or slightly hyperintense on T2-weighted images); duodenal-wall thickening; cysts in the groove or/and duodenal wall.8 Others inclusion criteria will be being 18 years or older and having the capacity to give an informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Exclusion criteria will include a current pregnancy and the evidence of neoplasia (digestive or other).
研究者
相似试验
进行中（未招募）
1 期
Treatment of dumping syndrome with Lanreotide Autogeltreatment of the dumping syndrome with Lanreotide AutogelEUCTR2007-001078-94-NLRadboud University medical centre12
尚未招募
4 期
Treatment of dumping syndrome with Lanreotide AutogelDumping syndrome10018012NL-OMON31107niversitair Medisch Centrum Sint Radboud12
进行中（未招募）
不适用
Evaluation of the effect of pasireotide LAR administration in the lymphocele prevention after axillary node dissection for breast cancer - SOM 230MedDRA version: 12.1Level: LLTClassification code 10006187Term: Breast cancerBREAST CANCEREUCTR2010-018795-24-FRAlliance pour la recherche en cancérologie
进行中（未招募）
不适用
Maintenance treatment with Lanreotide in Patients with small cell lung cancer expressing SST receptors, responsive to a first line standard chemotherapy/radiotherapySmall cell lung cancerEUCTR2011-005730-20-ITA.O. UNIVERSITARIA INTEGRATA DI VERONA134
进行中（未招募）
不适用
High-dose lanreotide in patients with acromegalyMedDRA version: 14.1Level: PTClassification code 10000599Term: AcromegalySystem Organ Class: 10014698 - Endocrine disordersacromegalyEUCTR2012-005313-39-ITAZIENDA OSPEDALIERA Spedali Civili di Brescia30